PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 136 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2019. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $260,000 | -45.7% | 29,747 | -33.1% | 0.00% | -100.0% |
| Q3 2019 | $479,000 | -15.2% | 44,469 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $565,000 | -39.4% | 44,469 | +40.8% | 0.00% | 0.0% |
| Q1 2019 | $933,000 | +190.7% | 31,572 | +100.0% | 0.00% | – |
| Q4 2018 | $321,000 | -55.7% | 15,786 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $724,000 | -22.5% | 15,786 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $934,000 | -13.0% | 15,786 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $1,074,000 | -33.7% | 15,786 | -3.7% | 0.00% | -50.0% |
| Q4 2017 | $1,620,000 | -13.0% | 16,386 | +5.4% | 0.00% | -33.3% |
| Q3 2017 | $1,862,000 | – | 15,545 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |